Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerJulie R. Brahmer, Jon M. Wigginton, Suzanne L. Topalian et al.|New England Journal of Medicine|2012Cited by 8k
Adjuvant high‐dose interferon for cutaneous melanoma is most beneficial for patients with early stage III diseaseDaniel A. Anaya, Janice N. Cormier, Yan Xing et al.|Cancer|2008Cited by 20